ACP-105
外观
| 法律規範狀態 | |
|---|---|
| 法律規範 | |
| 识别信息 | |
| |
| CAS号 | 1048998-11-3 |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| 化学信息 | |
| 化学式 | C16H19ClN2O |
| 摩尔质量 | 290.79 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
ACP-105是一种含氮有机氯化合物,化学式C16H19ClN2O,带有莨菪烷基团,能用作选择性雄激素受体调节剂(SARM)。[1][2][3][4]
参考文献
[编辑]- ^ Schlienger N, Lund BW, Pawlas J, Badalassi F, Bertozzi F, Lewinsky R, et al. Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators. Journal of Medicinal Chemistry. November 2009, 52 (22): 7186–7191. PMID 19856921. doi:10.1021/jm901149c.
- ^ Dayger C, Villasana L, Pfankuch T, Davis M, Raber J. Effects of the SARM ACP-105 on rotorod performance and cued fear conditioning in sham-irradiated and irradiated female mice. Brain Research. March 2011, 1381: 134–140. PMC 3048897
. PMID 21219889. doi:10.1016/j.brainres.2010.12.088.
- ^ George S, Petit GH, Gouras GK, Brundin P, Olsson R. Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer's disease. ACS Chemical Neuroscience. December 2013, 4 (12): 1537–1548. PMC 3867967
. PMID 24020966. doi:10.1021/cn400133s.
- ^ Cutler C, Viljanto M, Taylor P, Hincks P, Biddle S, Van Eenoo P. Identification of equine in vitro metabolites of seven non-steroidal selective androgen receptor modulators for doping control purposes. Drug Testing and Analysis. October 2021, 14 (2): 349–370. PMID 34714606. S2CID 240152623. doi:10.1002/dta.3189. hdl:1854/LU-8740373
.